← Back
$SABS All transactions

SAB Biotherapeutics, Inc.

A

$ Value

$0

Shares

240,000

Price

$0

Filed

Jan 7

Insider

Name

ZACCARDELLI DAVID

Title

CIK

0001627642

Roles

Director

Transaction Details

Transaction Date

2026-01-05

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

240,000

Footnotes

Represents the inaugural grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in three equal annual installments on January 5, 2027, January 5, 2028 and January 5, 2029. | This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.

Filing Info

Accession No.

0001193125-26-006427

Form Type

4

Issuer CIK

0001833214

ZACCARDELLI DAVID's History

Date Ticker Type Value
2026-01-05 SABS A $0
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA M
2025-10-07 VRNA M
2025-10-07 VRNA A
2025-10-07 VRNA M
2025-08-29 VRNA G $0

Other Insiders at SABS (90d)

Insider Bought Sold Last
Reich Samuel J
CEO
2026-02-03
Kropotova Alexandra
CHIEF MEDICAL OFFICER
2026-03-24
Sullivan Eddie Joe
PRESIDENT
2026-02-03
Bausch Christoph Lawrence
CHIEF OPERATING OFFICER
2026-02-03
To Lucy
See Remarks
2026-02-03